CADAMURO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 6.520
EU - Europa 3.175
AS - Asia 2.270
SA - Sud America 132
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 12.138
Nazione #
US - Stati Uniti d'America 6.410
SG - Singapore 877
CN - Cina 721
IT - Italia 640
SE - Svezia 477
RU - Federazione Russa 446
IE - Irlanda 440
DE - Germania 439
HK - Hong Kong 316
UA - Ucraina 252
GB - Regno Unito 168
BR - Brasile 122
CA - Canada 102
ID - Indonesia 92
FI - Finlandia 90
IN - India 57
FR - Francia 46
TR - Turchia 44
AT - Austria 35
NL - Olanda 34
DK - Danimarca 29
JP - Giappone 28
VN - Vietnam 27
KR - Corea 23
BE - Belgio 20
TW - Taiwan 20
EU - Europa 12
CZ - Repubblica Ceca 10
ES - Italia 10
NO - Norvegia 10
IR - Iran 9
PK - Pakistan 8
PL - Polonia 8
BD - Bangladesh 7
IQ - Iraq 7
CH - Svizzera 6
EG - Egitto 6
IL - Israele 6
MX - Messico 6
PH - Filippine 5
RO - Romania 5
MA - Marocco 4
MY - Malesia 4
NZ - Nuova Zelanda 4
AR - Argentina 3
BG - Bulgaria 3
CO - Colombia 3
NG - Nigeria 3
TH - Thailandia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
PA - Panama 2
SA - Arabia Saudita 2
TN - Tunisia 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
KH - Cambogia 1
LV - Lettonia 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SN - Senegal 1
Totale 12.138
Città #
Ann Arbor 989
Singapore 601
Fairfield 568
Woodbridge 545
Chandler 457
Houston 438
Dublin 425
Ashburn 335
Frankfurt am Main 287
Hong Kong 282
Wilmington 278
Jacksonville 269
Seattle 246
New York 235
Dearborn 224
Santa Clara 194
Milan 191
Cambridge 181
Princeton 145
Nanjing 106
Jakarta 89
Shanghai 82
Beijing 56
Lawrence 55
Guangzhou 53
Hangzhou 46
Lachine 46
Altamura 37
Helsinki 35
Boardman 33
San Diego 32
Shenyang 32
Council Bluffs 31
Rome 30
Andover 27
Los Angeles 25
Munich 24
Nanchang 23
Nuremberg 23
Padova 23
Brussels 20
Ottawa 20
Toronto 20
Vienna 20
Zhengzhou 20
Fremont 19
Kunming 18
Pune 18
Hebei 17
Changsha 16
London 16
Tianjin 16
Mountain View 14
Jinan 13
Auburn Hills 12
Dong Ket 12
Jiaxing 12
Norwalk 10
Tokyo 10
Bergamo 9
Brasília 9
Cinisello Balsamo 9
Genoa 9
Hefei 9
Lissone 9
New Haven 9
Pisa 9
Redmond 9
Bonndorf 8
Chicago 8
Huizen 8
Kiev 8
Ningbo 8
Washington 8
Yuseong-gu 8
Appiano Gentile 7
Bari 7
Carate Brianza 7
Chang-hua 7
Lappeenranta 7
Oslo 7
São Paulo 7
Taizhou 7
Assago 6
Brescia 6
Brno 6
Casalserugo 6
Central 6
Edmonton 6
Ha Kwai Chung 6
Monza 6
Shenzhen 6
Udine 6
Xi'an 6
Basiano 5
Belo Horizonte 5
Chengdu 5
Falls Church 5
Foshan 5
Fuzhou 5
Totale 8.390
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 491
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 375
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 319
Nephrosphere-Derived Cells are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 304
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 242
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 210
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 206
A ploidy increase promotes sensitivity of glioma stem cells to aurora kinases inhibition 203
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 192
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 189
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 187
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 182
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 181
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 180
Cholangiocyte biology as relevant to cystic liver diseases 179
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 175
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 173
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 169
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 167
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 165
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 164
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 162
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 161
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 159
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 157
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 154
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 152
Emerging concepts in biliary repair and fibrosis 152
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 151
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 149
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 145
Animal models of cholestasis: An update on inflammatory cholangiopathies 145
The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma 143
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 142
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 141
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 140
Protein kinase a-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis 138
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM. 138
The patient presenting with isolated hyperbilirubinemia 137
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 135
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C 132
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 129
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 125
Cxcl1 and cxcl10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 124
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 122
Role of angiogenesis and angiogenic factors for cholangiocyte growth 119
β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis 119
CXCL1 and CXCL10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 118
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 118
Notch signaling and progenitor/ductular reaction in steatohepatitis 118
The healthy biliary tree: Cellular and immune biology 117
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts 116
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 116
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 114
Leukaemia Inhibitory Factor Protects Cholangiocarcinoma Cells From Cytotoxicity Via MCL-1 112
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 104
Animal models for cystic fibrosis liver disease (CFLD) 104
Animal models of cholangiocarcinoma: What they teach us about the human disease 96
Oxidative Stress in Non-Autoimmune Liver Diseases 94
Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma 93
Colestasi intraepatica 90
The multitasking behavior of cholangiocyte in the reaction to liver damage 90
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 88
Cirrosi Biliare Primitiva 86
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 85
Colangite Sclerosante Primitiva 84
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 83
RAC1 and CDC42 activation regulates pdgf‐d mediated caf recruitment by cancer cells in cholangiocarcinoma 83
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 74
Colestasi Genetiche 72
Tumor microenvironment and immunology of cholangiocarcinoma 71
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 70
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 69
Life without notch: Liver repair in Alagille syndrome 61
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis 58
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 56
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 56
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 56
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia 53
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis 48
Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma 46
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 46
Paracrine platelet-derived growth factor-d (pdgf-d) signaling mediates cancer-associated fibroblast recruitment in cholangiocarcinoma 45
The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit 45
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 42
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma 41
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 41
Inhibition of YAP activation induces cell senescence and autophagy while blocking cell proliferation in cholangiocarcinoma (CCA) 40
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 40
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 40
CANCER ASSOCIATED FIBROBLASTS RECRUITMENT IS MEDIATED BY PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALING IN CHOLANGIOCARCINOMA 40
Cholangiocarcinoma 36
Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma 36
Altered Jagged-1/Notch signalling influences liver repair mechanisms in Alagille syndrome 36
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 35
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 35
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 35
Congenital cystic lesions of the biliary tree 35
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention 34
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 33
Totale 11.958
Categoria #
all - tutte 53.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020222 0 0 0 0 0 0 0 0 0 81 102 39
2020/20211.335 94 142 139 141 124 86 127 110 119 108 78 67
2021/2022722 52 69 92 45 27 50 31 37 36 67 85 131
2022/20231.670 167 501 166 161 118 240 26 89 100 12 45 45
2023/20242.104 76 70 68 131 351 467 355 103 223 19 39 202
2024/20252.723 275 532 334 175 388 221 229 203 366 0 0 0
Totale 12.717